VieCure
About VieCure
Products & Services
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Venture Round T: - FT: Venture Round |
A: 43000000 MR: - FA: $43 million FAN: 43000000 |
D: 2026-01-12 FD: 2026-01-12 |
5 investors |
Growth Metrics
Team & Leadership
Fred Ashbury
Chief Scientific Officer
Jennifer Choi
Chief - Division of Oncodermatology, Robert H. Lurie Comprehensive Cancer Center, Associate Professor, Dermatology, Feinberg School of Medicine, Northwestern University
Pradip De
Signal Transduction Pathway Consultant - Viecure
Stephen “Fred” Divers
Chief Medical Officer
Doug Flora
Executive Medical Director of Oncology Services
Sashikant Kulkarni
Professor, Molecular and Human Genetics, Baylor College of Medicine, Texas, USA
Recent News
VieCure Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- viecure.com
- Industries
- Healthcare/Oncology
- Company Size
- ~440 employees (est.)
Similar Companies
Discover AI-powered company recommendations based on industry, funding, and team profiles.
Upgrade to ProTechnology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro